|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.850 USD | +2.09% |
|
+3.54% | -26.51% |
| 06-16 | DiaMedica Therapeutics Inc. Receives FDA Feedback on DM199 Preeclampsia Nonclinical Program | CI |
| 06-16 | DiaMedica Therapeutics Receives US FDA Guidance on DM199 Nonclinical Requirements | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.09% | +3.54% | +1.39% | -13.46% | -26.51% | +62.05% | +60.71% | -22.00% | +28.29% | 315M | |
| +1.76% | +3.52% | +12.41% | +33.97% | +9.93% | +69.10% | +117.02% | +195.13% | +6,836.62% | 55.19B | |
| +4.60% | +3.02% | -1.45% | +13.00% | +13.33% | +57.38% | +62.27% | -29.64% | - | 45.75B | |
| -1.44% | +0.39% | -0.04% | +1.81% | -4.53% | -14.68% | -15.42% | -59.80% | - | 22.98B | |
| -2.69% | -2.10% | -12.54% | -29.56% | -44.96% | -6.70% | +363.03% | +232.99% | +884.58% | 20.76B | |
| -0.45% | -0.78% | -6.23% | -5.31% | -2.42% | +25.22% | -18.73% | -77.29% | - | 16.26B | |
| -0.29% | +2.45% | -5.25% | -1.36% | -19.44% | +20.69% | -37.29% | -39.47% | +41.02% | 15.42B | |
| -1.01% | -2.30% | +4.55% | +25.78% | +18.43% | +28.59% | +173.07% | +128.28% | +576.79% | 13.05B | |
| +4.95% | +11.70% | +32.83% | +65.62% | +125.53% | +125.78% | +261.94% | +1,221.70% | +413.70% | 12.45B | |
| -5.53% | -6.73% | -17.55% | -1.66% | -0.31% | +19.35% | - | - | - | 12.37B | |
| +1.18% | +5.20% | -1.53% | +14.64% | -13.15% | +77.00% | +109.95% | +375.55% | - | 11.66B | |
| +0.96% | +9.80% | +8.31% | +45.25% | +23.24% | +434.07% | +130.28% | -8.90% | +1,348.14% | 11.52B | |
| +0.86% | +12.30% | +0.92% | +27.68% | +23.98% | +142.92% | +118.11% | +261.87% | +783.18% | 10.7B | |
| -2.27% | -1.86% | -21.29% | -11.35% | -21.38% | -33.12% | +389.32% | +110.57% | +72.99% | 10.67B | |
| -5.20% | -7.11% | -28.82% | -25.96% | -26.55% | -12.82% | +149.62% | +38.68% | - | 10.29B | |
| +0.06% | +0.15% | +21.92% | +30.24% | +22.71% | +64.57% | +187.38% | - | - | 9.75B | |
| -2.63% | -7.48% | -21.29% | -23.58% | -7.29% | +20.27% | +116.02% | -47.02% | - | 7.8B | |
| +5.29% | +3.66% | -4.91% | -13.11% | +271.72% | +156.45% | +158.25% | -46.55% | - | 7.71B | |
| +0.97% | +9.35% | +18.86% | +114.16% | +169.66% | +488.54% | +3,221.05% | -44.53% | -18.95% | 7.67B | |
| +1.52% | +8.39% | +8.55% | -5.99% | +11.49% | +56.50% | -2.96% | +135.42% | - | 7.43B | |
| Average | +0.12% | +4.08% | -0.56% | +12.04% | +26.17% | +89.06% | +291.77% | +129.17% | +1,096.64% | 15.49B | |
| Weighted average by Cap. | +0.59% | +2.77% | +0.67% | +14.08% | +16.43% | +71.00% | +200.19% | +126.82% | +2,748.43% |
- Stock Market
- Stocks
- DMAC Stock
- Sector DiaMedica Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
